164 related articles for article (PubMed ID: 7742758)
21. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience.
Cuthbert RJ; Shepherd JD; Nantel SH; Barnett MJ; Reece DE; Klingemann HG; Chan KW; Spinelli JJ; Sutherland HJ; Phillips GL
Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957
[TBL] [Abstract][Full Text] [Related]
22. Thyroid function in children after allogeneic bone marrow transplantation.
Borgström B; Bolme P
Bone Marrow Transplant; 1994 Jan; 13(1):59-64. PubMed ID: 8019454
[TBL] [Abstract][Full Text] [Related]
23. Cataracts after autologous bone marrow transplantation in children.
Frisk P; Hagberg H; Mandahl A; Söderberg P; Lönnerholm G
Acta Paediatr; 2000 Jul; 89(7):814-9. PubMed ID: 10943964
[TBL] [Abstract][Full Text] [Related]
24. Renal toxicity in children undergoing total body irradiation for bone marrow transplant.
Esiashvili N; Chiang KY; Hasselle MD; Bryant C; Riffenburgh RH; Paulino AC
Radiother Oncol; 2009 Feb; 90(2):242-6. PubMed ID: 18973960
[TBL] [Abstract][Full Text] [Related]
25. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
Bailey HK; Kappy MS; Giller RH; Gralla J
Pediatr Blood Cancer; 2008 Sep; 51(3):405-9. PubMed ID: 18523993
[TBL] [Abstract][Full Text] [Related]
26. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
[TBL] [Abstract][Full Text] [Related]
27. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
28. Long-term renal function following bone marrow transplantation.
Grönroos MH; Bolme P; Winiarski J; Berg UB
Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393
[TBL] [Abstract][Full Text] [Related]
29. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
[TBL] [Abstract][Full Text] [Related]
30. Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
Anderson JE; Appelbaum FR; Schoch G; Barnett T; Chauncey TR; Flowers ME; Storb R
Biol Blood Marrow Transplant; 2001; 7(3):163-70. PubMed ID: 11302550
[TBL] [Abstract][Full Text] [Related]
31. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
32. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of dose homogenization and radiation carcinogenesis risk in total body irradiation for bone marrow transplantation.
Oysul K; Dirican B; Beyzadeoglu M; Sürenkok S; Arpaci F; Pak Y
Neoplasma; 2003; 50(5):372-6. PubMed ID: 14628091
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
[TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
[TBL] [Abstract][Full Text] [Related]
37. [Cyclophosphamide and total lymph node irradiation as conditioning for bone marrow transplant in severe aplastic anemia].
Sotti G; Rigon A; Polico C; Scarzello G; Friso ML; Calzavara F; Fabbris R; Cauzzo C
Radiol Med; 1987 Jun; 73(6):545-6. PubMed ID: 3299513
[TBL] [Abstract][Full Text] [Related]
38. [Whole-body irradiation for bone marrow transplantation].
Di Pietrantonj F; Proietti A; Capirci C
Radiol Med; 1984 Jun; 70(6):396-410. PubMed ID: 6398469
[TBL] [Abstract][Full Text] [Related]
39. Endocrine function after bone marrow transplantation without the use of preparative total body irradiation.
Urban C; Schwingshandl J; Slavc I; Gamillscheg A; Hauer C; Schmid G; Kaulfersch W; Borkenstein M
Bone Marrow Transplant; 1988 Jul; 3(4):291-6. PubMed ID: 3048494
[TBL] [Abstract][Full Text] [Related]
40. Normal neurodevelopment in four young children treated with bone marrow transplantation for acute leukemia or aplastic anemia.
Kaleita TA; Shields WD; Tesler A; Feig SA
Pediatrics; 1989 May; 83(5):753-7. PubMed ID: 2654868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
